Eli Lilly's Amyvid is injected into patients who then get a PET scan. A negative diagnosis rules out Alzheimer's.
Monday, May 9, 2011
Current medications are most effective in the early stages of Alzheimer's disease. That's why the FDA may approve a new chemical that can highlight Alzheimer's signs in the brain.